These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 1717717)

  • 101. HIV envelope trimers and gp120 as immunogens to induce broadly neutralizing antibodies in cows.
    Altman PX; Parren M; Sang H; Ozorowski G; Lee WH; Smider VV; Wilson IA; Ward AB; Mwangi W; Burton DR; Sok D
    bioRxiv; 2024 Mar; ():. PubMed ID: 38585787
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Engaging an HIV vaccine target through the acquisition of low B cell affinity.
    Ronsard L; Yousif AS; Nait Mohamed FA; Feldman J; Okonkwo V; McCarthy C; Schnabel J; Caradonna T; Barnes RM; Rohrer D; Lonberg N; Schmidt A; Lingwood D
    Nat Commun; 2023 Aug; 14(1):5249. PubMed ID: 37640732
    [TBL] [Abstract][Full Text] [Related]  

  • 103.
    Laval F; Coppin G; Twizere JC; Vidal M
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298131
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Characterization of the Human Immunodeficiency Virus (HIV-1) Envelope Glycoprotein Conformational States on Infectious Virus Particles.
    Nguyen HT; Wang Q; Anang S; Sodroski JG
    J Virol; 2023 Mar; 97(3):e0185722. PubMed ID: 36815832
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Long-Acting BMS-378806 Analogues Stabilize the State-1 Conformation of the Human Immunodeficiency Virus Type 1 Envelope Glycoproteins.
    Zou S; Zhang S; Gaffney A; Ding H; Lu M; Grover JR; Farrell M; Nguyen HT; Zhao C; Anang S; Zhao M; Mohammadi M; Blanchard SC; Abrams C; Madani N; Mothes W; Kappes JC; Smith AB; Sodroski J
    J Virol; 2020 May; 94(10):. PubMed ID: 32161177
    [TBL] [Abstract][Full Text] [Related]  

  • 106. CD4-Binding Site Directed Cross-Neutralizing scFv Monoclonals from HIV-1 Subtype C Infected Indian Children.
    Kumar S; Kumar R; Khan L; Makhdoomi MA; Thiruvengadam R; Mohata M; Agarwal M; Lodha R; Kabra SK; Sinha S; Luthra K
    Front Immunol; 2017; 8():1568. PubMed ID: 29187855
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Semisynthetic Bioluminescent Sensor Proteins for Direct Detection of Antibodies and Small Molecules in Solution.
    Arts R; Ludwig SKJ; van Gerven BCB; Estirado EM; Milroy LG; Merkx M
    ACS Sens; 2017 Nov; 2(11):1730-1736. PubMed ID: 29037030
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Cross-Linking of a CD4-Mimetic Miniprotein with HIV-1 Env gp140 Alters Kinetics and Specificities of Antibody Responses against HIV-1 Env in Macaques.
    Shen X; Bogers WM; Yates NL; Ferrari G; Dey AK; Williams WT; Jaeger FH; Wiehe K; Sawant S; Alam SM; LaBranche CC; Montefiori DC; Martin L; Srivastava I; Heeney J; Barnett SW; Tomaras GD
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28490585
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Antigenicity and immunogenicity of a trimeric envelope protein from an Indian clade C HIV-1 isolate.
    Sneha Priya R; Veena M; Kalisz I; Whitney S; Priyanka D; LaBranche CC; Sri Teja M; Montefiori DC; Pal R; Mahalingam S; Kalyanaraman VS
    J Biol Chem; 2015 Apr; 290(14):9195-208. PubMed ID: 25691567
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Stabilizing exposure of conserved epitopes by structure guided insertion of disulfide bond in HIV-1 envelope glycoprotein.
    Kassa A; Dey AK; Sarkar P; Labranche C; Go EP; Clark DF; Sun Y; Nandi A; Hartog K; Desaire H; Montefiori D; Carfi A; Srivastava IK; Barnett SW
    PLoS One; 2013; 8(10):e76139. PubMed ID: 24146829
    [TBL] [Abstract][Full Text] [Related]  

  • 111. The role of neutralizing antibodies in prevention of HIV-1 infection: what can we learn from the mother-to-child transmission context?
    Braibant M; Barin F
    Retrovirology; 2013 Oct; 10():103. PubMed ID: 24099103
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Recombinant HIV envelope proteins fail to engage germline versions of anti-CD4bs bNAbs.
    Hoot S; McGuire AT; Cohen KW; Strong RK; Hangartner L; Klein F; Diskin R; Scheid JF; Sather DN; Burton DR; Stamatatos L
    PLoS Pathog; 2013 Jan; 9(1):e1003106. PubMed ID: 23300456
    [TBL] [Abstract][Full Text] [Related]  

  • 113. The development of CD4 binding site antibodies during HIV-1 infection.
    Lynch RM; Tran L; Louder MK; Schmidt SD; Cohen M; ; Dersimonian R; Euler Z; Gray ES; Abdool Karim S; Kirchherr J; Montefiori DC; Sibeko S; Soderberg K; Tomaras G; Yang ZY; Nabel GJ; Schuitemaker H; Morris L; Haynes BF; Mascola JR
    J Virol; 2012 Jul; 86(14):7588-95. PubMed ID: 22573869
    [TBL] [Abstract][Full Text] [Related]  

  • 114. MiniCD4 protein resistance mutations affect binding to the HIV-1 gp120 CD4 binding site and decrease entry efficiency.
    Grupping K; Selhorst P; Michiels J; Vereecken K; Heyndrickx L; Kessler P; Vanham G; Martin L; Ariën KK
    Retrovirology; 2012 May; 9():36. PubMed ID: 22551420
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Elicitation of neutralizing antibodies directed against CD4-induced epitope(s) using a CD4 mimetic cross-linked to a HIV-1 envelope glycoprotein.
    Dey AK; Burke B; Sun Y; Sirokman K; Nandi A; Hartog K; Lian Y; Geonnotti AR; Montefiori D; Franti M; Martin G; Carfi A; Kessler P; Martin L; Srivastava IK; Barnett SW
    PLoS One; 2012; 7(1):e30233. PubMed ID: 22291921
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Enhanced HIV-1 neutralization by antibody heteroligation.
    Mouquet H; Warncke M; Scheid JF; Seaman MS; Nussenzweig MC
    Proc Natl Acad Sci U S A; 2012 Jan; 109(3):875-80. PubMed ID: 22219363
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Requirements for empirical immunogenicity trials, rather than structure-based design, for developing an effective HIV vaccine.
    Van Regenmortel MH
    Arch Virol; 2012 Jan; 157(1):1-20. PubMed ID: 22012269
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Memory B cell antibodies to HIV-1 gp140 cloned from individuals infected with clade A and B viruses.
    Mouquet H; Klein F; Scheid JF; Warncke M; Pietzsch J; Oliveira TY; Velinzon K; Seaman MS; Nussenzweig MC
    PLoS One; 2011; 6(9):e24078. PubMed ID: 21931643
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding.
    Scheid JF; Mouquet H; Ueberheide B; Diskin R; Klein F; Oliveira TY; Pietzsch J; Fenyo D; Abadir A; Velinzon K; Hurley A; Myung S; Boulad F; Poignard P; Burton DR; Pereyra F; Ho DD; Walker BD; Seaman MS; Bjorkman PJ; Chait BT; Nussenzweig MC
    Science; 2011 Sep; 333(6049):1633-7. PubMed ID: 21764753
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Phylogenetic analysis consistent with a clinical history of sexual transmission of HIV-1 from a single donor reveals transmission of highly distinct variants.
    English S; Katzourakis A; Bonsall D; Flanagan P; Duda A; Fidler S; Weber J; McClure M; ; Phillips R; Frater J
    Retrovirology; 2011 Jul; 8():54. PubMed ID: 21736738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.